A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma
Clinical trial NCT01949883 · COMPLETED
Trial details
- NCT number
- NCT01949883
- Sponsor
- Constellation Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-05
- Primary completion
- 2017-12-20
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.